Risankizumab is effective following ustekinumab failure in Crohn’s disease: A real-world study from a tertiary center

Figure 1 Box plots demonstrating mean measurements of clinical and biochemical parameters over the different timepoints in our study. A: Mean harvey bradshaw index over time; B: Mean faecal calprotectin (μg/g) over time; C: Mean serum albumin (g/L) over time; D: Mean C-reactive protein (mg/L) over time. HBI: Harvey-Bradshaw Index; CRP: C-reactive protein.

Figure 2 Box and whisker plots of the data points over time. The boxes represent interquartile ranges from 25^th to 75^th. The horizontal lines within each box represent the median value. The whiskers extend to the smallest and largest values within 1.5 × the interquartile range from the lower and upper quartiles. Dots represent outliers. A: Harvey bradshaw index over time; B: Mean faecal calprotectin (μg/g) over time; C: Mean serum albumin (g/L) over time; D: Mean C-reactive protein (mg/L) over time. HBI: Harvey-Bradshaw Index; FCP: Faecal calprotectin; CRP: C-reactive protein.

Figure 3  Box plot of observed clinical remission rate, defined as Harvey-Bradshaw Index, over time.